Add time:09/08/2019 Source:sciencedirect.com
Two studies involving six healthy volunteers were carried out to assess the importance of biphasic rapid and sustained release of oleic acid in enhancing the bioavailability of propranolol using the HALOTM drug delivery system. The results of the first study showed that mean Cmax and AUC values for propranolol were increased by at least 300% using biphasic HALOTM-propranolol capsules compared with Half Inderal® LA, both containing an 80mg dose of propranolol. In the second study no significant differences in propranolol bioavailability were observed between monophasic enteric-coated capsules containing only the sustained release component of the HALOTM delivery system and Half Inderal® LA, when an equivalent 80mg dose of propranolol was administered. The use of improved enteric-coating procedures increased propranolol bioavailability compared with previous studies using biphasic HALOTM-propranolol capsules. The possible explanations for the effectiveness of biphasic rapid and sustained delivery of oleic acid for enhancing the bioavailability of propranolol are discussed.
We also recommend Trading Suppliers and Manufacturers of propranolol laurate (cas 138656-55-0). Pls Click Website Link as below: cas 138656-55-0 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View